APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pirfenidone Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pirfenidone Tablets Industry Growth and Trends Forecast to 2032

27 December 202595 pages

Choose your research edition.

Industry ResearchPirfenidone Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pirfenidone Tablets Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pirfenidone Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pirfenidone Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pirfenidone Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pirfenidone Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pirfenidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pirfenidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pirfenidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pirfenidone Tablets include Teva, Roche, Kawin, ScieGen Pharmaceuticals, Sandoz, Apotex, Amneal Pharmaceuticals and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pirfenidone Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pirfenidone Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pirfenidone Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pirfenidone Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pirfenidone Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pirfenidone Tablets Market by Company

Teva

Roche

Kawin

ScieGen Pharmaceuticals

Sandoz

Apotex

Amneal Pharmaceuticals

Accord Healthcare

Pirfenidone Tablets Segment by Type

200mg per Tablet

267mg per Tablet

801mg per Tablet

Pirfenidone Tablets Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Pirfenidone Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pirfenidone Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pirfenidone Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pirfenidone Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pirfenidone Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pirfenidone Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 200mg per Tablet Table 2. Major Company of 267mg per Tablet Table 3. Major Company of 801mg per Tablet Table 4. Global Pirfenidone Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pirfenidone Tablets Sales by Type (2021-2026) & (K Units) Table 6. Global Pirfenidone Tablets Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pirfenidone Tablets Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pirfenidone Tablets Sales Market Share in Value by Type (2021-2026) Table 9. Global Pirfenidone Tablets Price by Type (2021-2026) & (US$/Unit) Table 10. Global Pirfenidone Tablets Sales by Type (2027-2032) & (K Units) Table 11. Global Pirfenidone Tablets Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pirfenidone Tablets Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pirfenidone Tablets Sales Market Share in Value by Type (2027-2032) Table 14. Global Pirfenidone Tablets Price by Type (2027-2032) & (US$/Unit) Table 15. North America Pirfenidone Tablets Sales by Type (2021-2026) & (K Units) Table 16. North America Pirfenidone Tablets Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pirfenidone Tablets Sales by Type (2021-2026) & (K Units) Table 18. Europe Pirfenidone Tablets Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pirfenidone Tablets Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Pirfenidone Tablets Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pirfenidone Tablets Sales by Type (2021-2026) & (K Units) Table 22. Latin America Pirfenidone Tablets Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pirfenidone Tablets Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Pirfenidone Tablets Sales by Type (2021-2026) & (US$ Million) Table 25. Pirfenidone Tablets Industry Trends Table 26. Pirfenidone Tablets Industry Drivers Table 27. Pirfenidone Tablets Industry Opportunities and Challenges Table 28. Pirfenidone Tablets Industry Restraints Table 29. Global Pirfenidone Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pirfenidone Tablets Revenue Market Share by Company (2021-2026) Table 31. Global Pirfenidone Tablets Sales by Company (2021-2026) & (K Units) Table 32. Global Pirfenidone Tablets Sales Share by Company (2021-2026) Table 33. Global Pirfenidone Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Pirfenidone Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pirfenidone Tablets Major Company Production Sites and Headquarters Table 36. Global Pirfenidone Tablets Company, Product Type & Application Table 37. Global Pirfenidone Tablets Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pirfenidone Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pirfenidone Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pirfenidone Tablets Sales by Region (2021-2026) & (K Units) Table 42. Global Pirfenidone Tablets Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pirfenidone Tablets Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pirfenidone Tablets Sales Market Share in Value by Region (2021-2026) Table 45. Global Pirfenidone Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Pirfenidone Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Pirfenidone Tablets Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pirfenidone Tablets Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pirfenidone Tablets Sales Market Share in Value by Region (2027-2032) Table 50. Global Pirfenidone Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Pirfenidone Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pirfenidone Tablets Sales by Application (2021-2026) & (K Units) Table 53. Global Pirfenidone Tablets Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pirfenidone Tablets Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pirfenidone Tablets Sales Market Share in Value by Application (2021-2026) Table 56. Global Pirfenidone Tablets Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pirfenidone Tablets Sales by Application (2027-2032) & (K Units) Table 58. Global Pirfenidone Tablets Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pirfenidone Tablets Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pirfenidone Tablets Sales Market Share in Value by Application (2027-2032) Table 61. Global Pirfenidone Tablets Price by Application (2027-2032) & (US$/Unit) Table 62. North America Pirfenidone Tablets Sales by Application (2021-2026) & (K Units) Table 63. North America Pirfenidone Tablets Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pirfenidone Tablets Sales by Application (2021-2026) & (K Units) Table 65. Europe Pirfenidone Tablets Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pirfenidone Tablets Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Pirfenidone Tablets Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pirfenidone Tablets Sales by Application (2021-2026) & (K Units) Table 69. Latin America Pirfenidone Tablets Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pirfenidone Tablets Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Pirfenidone Tablets Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Pirfenidone Tablets Product Portfolio Table 76. Teva Recent Development Table 77. Roche Company Information Table 78. Roche Business Overview Table 79. Roche Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Roche Pirfenidone Tablets Product Portfolio Table 81. Roche Recent Development Table 82. Kawin Company Information Table 83. Kawin Business Overview Table 84. Kawin Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Kawin Pirfenidone Tablets Product Portfolio Table 86. Kawin Recent Development Table 87. ScieGen Pharmaceuticals Company Information Table 88. ScieGen Pharmaceuticals Business Overview Table 89. ScieGen Pharmaceuticals Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. ScieGen Pharmaceuticals Pirfenidone Tablets Product Portfolio Table 91. ScieGen Pharmaceuticals Recent Development Table 92. Sandoz Company Information Table 93. Sandoz Business Overview Table 94. Sandoz Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sandoz Pirfenidone Tablets Product Portfolio Table 96. Sandoz Recent Development Table 97. Apotex Company Information Table 98. Apotex Business Overview Table 99. Apotex Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Apotex Pirfenidone Tablets Product Portfolio Table 101. Apotex Recent Development Table 102. Amneal Pharmaceuticals Company Information Table 103. Amneal Pharmaceuticals Business Overview Table 104. Amneal Pharmaceuticals Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Amneal Pharmaceuticals Pirfenidone Tablets Product Portfolio Table 106. Amneal Pharmaceuticals Recent Development Table 107. Accord Healthcare Company Information Table 108. Accord Healthcare Business Overview Table 109. Accord Healthcare Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Accord Healthcare Pirfenidone Tablets Product Portfolio Table 111. Accord Healthcare Recent Development Table 112. North America Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Pirfenidone Tablets Sales by Country (2021-2026) & (K Units) Table 114. North America Pirfenidone Tablets Sales Market Share by Country (2021-2026) Table 115. North America Pirfenidone Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Pirfenidone Tablets Sales Market Share Forecast by Country (2027-2032) Table 117. North America Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Pirfenidone Tablets Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Pirfenidone Tablets Market Share by Country (2021-2026) Table 120. North America Pirfenidone Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Pirfenidone Tablets Market Share Forecast by Country (2027-2032) Table 122. Europe Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Pirfenidone Tablets Sales by Country (2021-2026) & (K Units) Table 124. Europe Pirfenidone Tablets Sales Market Share by Country (2021-2026) Table 125. Europe Pirfenidone Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Pirfenidone Tablets Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Pirfenidone Tablets Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Pirfenidone Tablets Market Share by Country (2021-2026) Table 130. Europe Pirfenidone Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Pirfenidone Tablets Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Pirfenidone Tablets Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Pirfenidone Tablets Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Pirfenidone Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Pirfenidone Tablets Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Pirfenidone Tablets Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Pirfenidone Tablets Market Share by Country (2021-2026) Table 140. Asia-Pacific Pirfenidone Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Pirfenidone Tablets Market Share Forecast by Country (2027-2032) Table 142. Latin America Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Pirfenidone Tablets Sales by Country (2021-2026) & (K Units) Table 144. Latin America Pirfenidone Tablets Sales Market Share by Country (2021-2026) Table 145. Latin America Pirfenidone Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Pirfenidone Tablets Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Pirfenidone Tablets Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Pirfenidone Tablets Market Share by Country (2021-2026) Table 150. Latin America Pirfenidone Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Pirfenidone Tablets Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Pirfenidone Tablets Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Pirfenidone Tablets Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Pirfenidone Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Pirfenidone Tablets Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Pirfenidone Tablets Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Pirfenidone Tablets Market Share by Country (2021-2026) Table 160. Middle East and Africa Pirfenidone Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Pirfenidone Tablets Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Pirfenidone Tablets Distributors List Table 165. Pirfenidone Tablets Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Pirfenidone Tablets Image Figure 2. Global Pirfenidone Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pirfenidone Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Pirfenidone Tablets Sales (2021-2032) & (K Units) Figure 5. 200mg per Tablet Image Figure 6. Global 200mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 267mg per Tablet Image Figure 8. Global 267mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. 801mg per Tablet Image Figure 10. Global 801mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Pirfenidone Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pirfenidone Tablets Market Share by Type 2025 VS 2032 Figure 13. North America Pirfenidone Tablets Sales Market Share in Volume by Type in 2025 Figure 14. North America Pirfenidone Tablets Sales Market Share in Value by Type in 2025 Figure 15. Europe Pirfenidone Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pirfenidone Tablets Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pirfenidone Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pirfenidone Tablets Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pirfenidone Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pirfenidone Tablets Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pirfenidone Tablets Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pirfenidone Tablets Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pirfenidone Tablets Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital and Clinic Image Figure 28. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Pirfenidone Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pirfenidone Tablets Market Share by Application 2025 VS 2032 Figure 33. North America Pirfenidone Tablets Sales Market Share in Volume by Application in 2025 Figure 34. North America Pirfenidone Tablets Sales Market Share in Value by Application in 2025 Figure 35. Europe Pirfenidone Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pirfenidone Tablets Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pirfenidone Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pirfenidone Tablets Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pirfenidone Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pirfenidone Tablets Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pirfenidone Tablets Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pirfenidone Tablets Sales Market Share in Value by Application in 2025 Figure 43. North America Pirfenidone Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Pirfenidone Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pirfenidone Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pirfenidone Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pirfenidone Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Pirfenidone Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pirfenidone Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pirfenidone Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pirfenidone Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Pirfenidone Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pirfenidone Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pirfenidone Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pirfenidone Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Pirfenidone Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pirfenidone Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pirfenidone Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pirfenidone Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Pirfenidone Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pirfenidone Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pirfenidone Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pirfenidone Tablets Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pirfenidone Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg per Tablet
  • 267mg per Tablet
  • 801mg per Tablet
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • Teva
  • Roche
  • Kawin
  • ScieGen Pharmaceuticals
  • Sandoz
  • Apotex
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pirfenidone Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pirfenidone Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pirfenidone Tablets Market by Type
  6. 1.3.1 200mg per Tablet
  7. 1.3.2 267mg per Tablet
  8. 1.3.3 801mg per Tablet
  9. 1.4 Global Pirfenidone Tablets Market Size by Type
  10. 1.4.1 Global Pirfenidone Tablets Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pirfenidone Tablets Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pirfenidone Tablets Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pirfenidone Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pirfenidone Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pirfenidone Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pirfenidone Tablets Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pirfenidone Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pirfenidone Tablets Industry Trends
  2. 2.2 Pirfenidone Tablets Industry Drivers
  3. 2.3 Pirfenidone Tablets Industry Opportunities and Challenges
  4. 2.4 Pirfenidone Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pirfenidone Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Pirfenidone Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Pirfenidone Tablets Price (2021-2026)
  4. 3.4 Global Pirfenidone Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pirfenidone Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Pirfenidone Tablets Company, Product Type & Application
  7. 3.7 Global Pirfenidone Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pirfenidone Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pirfenidone Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pirfenidone Tablets Tier 1, Tier 2, and Tier 3
4 Pirfenidone Tablets Regional Status and Outlook
  1. 4.1 Global Pirfenidone Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pirfenidone Tablets Historic Market Size by Region
  3. 4.2.1 Global Pirfenidone Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pirfenidone Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pirfenidone Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pirfenidone Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Pirfenidone Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pirfenidone Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pirfenidone Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pirfenidone Tablets by Application
  1. 5.1 Pirfenidone Tablets Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Pirfenidone Tablets Market Size by Application
  6. 5.2.1 Global Pirfenidone Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pirfenidone Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pirfenidone Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pirfenidone Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pirfenidone Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pirfenidone Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pirfenidone Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pirfenidone Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Pirfenidone Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pirfenidone Tablets Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Pirfenidone Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Pirfenidone Tablets Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Kawin
  14. 6.3.1 Kawin Company Information
  15. 6.3.2 Kawin Business Overview
  16. 6.3.3 Kawin Pirfenidone Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Kawin Pirfenidone Tablets Product Portfolio
  18. 6.3.5 Kawin Recent Developments
  19. 6.4 ScieGen Pharmaceuticals
  20. 6.4.1 ScieGen Pharmaceuticals Company Information
  21. 6.4.2 ScieGen Pharmaceuticals Business Overview
  22. 6.4.3 ScieGen Pharmaceuticals Pirfenidone Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ScieGen Pharmaceuticals Pirfenidone Tablets Product Portfolio
  24. 6.4.5 ScieGen Pharmaceuticals Recent Developments
  25. 6.5 Sandoz
  26. 6.5.1 Sandoz Company Information
  27. 6.5.2 Sandoz Business Overview
  28. 6.5.3 Sandoz Pirfenidone Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sandoz Pirfenidone Tablets Product Portfolio
  30. 6.5.5 Sandoz Recent Developments
  31. 6.6 Apotex
  32. 6.6.1 Apotex Company Information
  33. 6.6.2 Apotex Business Overview
  34. 6.6.3 Apotex Pirfenidone Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Apotex Pirfenidone Tablets Product Portfolio
  36. 6.6.5 Apotex Recent Developments
  37. 6.7 Amneal Pharmaceuticals
  38. 6.7.1 Amneal Pharmaceuticals Company Information
  39. 6.7.2 Amneal Pharmaceuticals Business Overview
  40. 6.7.3 Amneal Pharmaceuticals Pirfenidone Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Amneal Pharmaceuticals Pirfenidone Tablets Product Portfolio
  42. 6.7.5 Amneal Pharmaceuticals Recent Developments
  43. 6.8 Accord Healthcare
  44. 6.8.1 Accord Healthcare Company Information
  45. 6.8.2 Accord Healthcare Business Overview
  46. 6.8.3 Accord Healthcare Pirfenidone Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Accord Healthcare Pirfenidone Tablets Product Portfolio
  48. 6.8.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Pirfenidone Tablets Sales by Country
  2. 7.1.1 North America Pirfenidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pirfenidone Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Pirfenidone Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pirfenidone Tablets Market Size by Country
  6. 7.2.1 North America Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pirfenidone Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Pirfenidone Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pirfenidone Tablets Sales by Country
  2. 8.1.1 Europe Pirfenidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pirfenidone Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Pirfenidone Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pirfenidone Tablets Market Size by Country
  6. 8.2.1 Europe Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pirfenidone Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pirfenidone Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pirfenidone Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Pirfenidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pirfenidone Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pirfenidone Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pirfenidone Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pirfenidone Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pirfenidone Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pirfenidone Tablets Sales by Country
  2. 10.1.1 South America Pirfenidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pirfenidone Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Pirfenidone Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pirfenidone Tablets Market Size by Country
  6. 10.2.1 South America Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pirfenidone Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Pirfenidone Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pirfenidone Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Pirfenidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pirfenidone Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pirfenidone Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pirfenidone Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Pirfenidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pirfenidone Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pirfenidone Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pirfenidone Tablets Value Chain Analysis
  2. 12.1.1 Pirfenidone Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pirfenidone Tablets Production Mode & Process
  7. 12.2 Pirfenidone Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pirfenidone Tablets Distributors
  10. 12.2.3 Pirfenidone Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst